TREATMENT OF KAPOSIS SARCOMA WITH ICRF-159 (NSC-129943)

被引：0
作者：
OLWENY, CLM
MASABA, JP
SIKYEWUNDA, W
TOYA, T
机构：
[1] MAKERERE UNIV UGANDA CANC INST,KAMPALA,UGANDA
[2] MAKERERE UNIV,MED SCH,KAMPALA,UGANDA
来源：
CANCER TREATMENT REPORTS | 1976年 / 60卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：111 / 113
页数：3
相关论文
共 7 条
[1]   ANTITUMOUR ACTIVITY IN A SERIES OF BISDIKETOPIPERAZINES [J].
CREIGHTON, AM ;
HELLMANN, K ;
WHITECROSS, S .
NATURE, 1969, 222 (5191) :384-+
[2]  
HELLMANN K, 1970, J NATL CANCER I, V44, P539
[3]   CONTROL OF MALIGNANT METASTASES BY ICRF-159 [J].
HELLMANN, K ;
BURRAGE, K .
NATURE, 1969, 224 (5216) :273-&
[4]   PRELIMINARY CLINICAL ASSESSMENT OF ICRF 159 INACUTE LEUKAEMIA AND LYMPHOSARCOMA [J].
HELLMANN, K ;
NEWTON, KA ;
WHITMORE, DN ;
HANHAM, IWF ;
BOND, JV .
BRITISH MEDICAL JOURNAL, 1969, 1 (5647) :822-&
[5]   METASTASES AND NORMALIZATION OF TUMOR BLOOD-VESSELS BY ICRF 159 - NEW TYPE OF DRUG ACTION [J].
LESERVE, AW ;
HELLMANN, K .
BRITISH MEDICAL JOURNAL, 1972, 1 (5800) :597-&
[6]   MODE OF ACTION OF CYTOSTATIC AGENT ICRF-159 [J].
SHARPE, HBA ;
FIELD, EO ;
HELLMANN, K .
NATURE, 1970, 226 (5245) :524-&
[7]   KAPOSIS SARCOMA IN UGANDA - CLINICO-PATHOLOGICAL STUDY [J].
TAYLOR, JF ;
TEMPLETON, AC ;
VOGEL, CL ;
ZIEGLER, JL ;
KYALWAZI, SK .
INTERNATIONAL JOURNAL OF CANCER, 1971, 8 (01) :122-+
1